[go: up one dir, main page]

AU4451501A - Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof - Google Patents

Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof

Info

Publication number
AU4451501A
AU4451501A AU44515/01A AU4451501A AU4451501A AU 4451501 A AU4451501 A AU 4451501A AU 44515/01 A AU44515/01 A AU 44515/01A AU 4451501 A AU4451501 A AU 4451501A AU 4451501 A AU4451501 A AU 4451501A
Authority
AU
Australia
Prior art keywords
inflammatory
manufacture
composition containing
selective cox
therapeutic anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44515/01A
Inventor
Rajesh Jain
Amarjit Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AU4451501A publication Critical patent/AU4451501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU44515/01A 2000-01-21 2001-01-19 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof Abandoned AU4451501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN46DE2000 IN191512B (en) 2000-01-21 2000-01-21
IN46/DEL/2000 2000-01-21
PCT/IN2001/000007 WO2001052897A2 (en) 2000-01-21 2001-01-19 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors

Publications (1)

Publication Number Publication Date
AU4451501A true AU4451501A (en) 2001-07-31

Family

ID=11097023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44515/01A Abandoned AU4451501A (en) 2000-01-21 2001-01-19 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof

Country Status (3)

Country Link
AU (1) AU4451501A (en)
IN (1) IN191512B (en)
WO (1) WO2001052897A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
IN191090B (en) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
HUP0600294A2 (en) * 2001-05-31 2007-02-28 Pharmacia Corp Skin-permeable selective cyclooxygenase-2 inhibitor composition
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
EP1534235B1 (en) * 2002-06-25 2016-07-27 Acrux DDS Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
UY27984A1 (en) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co PHARMACEUTICAL COMPOSITION FOR SUPPLY BY MELOXICAM TOPICS
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20040127531A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor
US20040126415A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor
US20050020658A1 (en) * 2002-11-21 2005-01-27 Katsuyuki Inoo Selective cyclooxygenase-2 inhibitor patch
WO2005044227A1 (en) * 2003-11-05 2005-05-19 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
RO122835B9 (en) * 2006-12-19 2010-06-30 Ion Fulga Use of diethylamine as an analgesic in pharmaceutical preparations
EP2488145B1 (en) 2009-10-12 2024-04-24 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
BR112012022073A2 (en) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh use of meloxicam for the long-term treatment of musculoskeletal disorders in cats.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EA023000B1 (en) * 2012-10-25 2016-04-29 Закрытое Акционерное Общество "Фармфирма "Сотекс" External medication for treatment of diseases of joints and soft tissues
WO2016015094A1 (en) * 2014-07-31 2016-02-04 Acrux Dds Pty Ltd Topical composition
AU2016270504A1 (en) * 2015-05-29 2017-12-14 Codadose Incorporated Liquid formulations of celecoxib for oral administration
WO2017197509A1 (en) * 2016-05-16 2017-11-23 Joseph Gabriele Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions
KR20230051117A (en) * 2020-01-10 2023-04-17 브리오리 바이오테크 인코포레이티드 Topical Compositions Containing Rofecoxib and Methods of Making and Using The Same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
GB9019413D0 (en) * 1990-09-05 1990-10-17 Beecham Group Plc Topical treatment and composition
ATE205391T1 (en) * 1994-10-05 2001-09-15 Helsinn Healthcare Sa NIMESULIDE FOR EXTERNAL USE
US6136839A (en) * 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
HUP9601443A3 (en) * 1996-05-29 1999-03-29 Panacea Biotec Ltd Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them
GB9804886D0 (en) * 1998-03-06 1998-04-29 Merck Sharp & Dohme Therapeutic combination
JP2002519310A (en) * 1998-06-29 2002-07-02 ファーマシューティカルズ アプリケーションズ アソシエイツ， エルエルシー Methods and transdermal compositions for pain relief

Also Published As

Publication number Publication date
IN191512B (en) 2003-12-06
WO2001052897A2 (en) 2001-07-26
WO2001052897A3 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU4451501A (en) Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
EP1330238A4 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
AU4209400A (en) Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU7031500A (en) Therapeutic quinazoline compounds
AU2002236647A1 (en) Method and device for administering medication and/or placebo
AU2003223005A1 (en) Application device for topical administration of pharmaceutical agents
HUP0300157A3 (en) Anti-inflammatory and analgesic heterocyclo-alkylsulfonyl pyrazole derivatives, process for their preparation and pharmaceutical compounds containing them
AU2003216581A1 (en) Pyrazole compounds as anti-inflammatory and analgesic agents
AU2001216218A1 (en) Heterocyclic analgesic compounds and method of use thereof
AU2001258395A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
AU6796096A (en) A novel therapeutic anti-inflammatory and analgesic pharmaceutical composition containing Nimesulide 4-Nitro, 2 phenoxyphenyl methane sulphonamide for use transdermally and a process for the manufacture thereof
AU2002210687A1 (en) Use of compound in the manufacture of a pharmaceutical for inhibiting steroid sulphatase and steroid dehydrogenase activity
AU4170299A (en) Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
AU2001243515A1 (en) Combination drug therapy
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
DE60121047D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PHIMOSIVE WITH A TOPICAL CORTICOSTEROID
HUP0301348A3 (en) Analgesic and anti-inflammatory compositions containing gox-2 inhibitors and their use
AU2003232874A1 (en) A pharmaceutical composition comprising a corticosteroid and a nonsterodial anti-inflammatory agent
AU2002218750A1 (en) Photoactivated drug therapy
AU2002240949A1 (en) Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase